https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Int. J. Oncol. 2004 Mar;24(3):623-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Int. J. Oncol. 2004 Mar;24(3):623-342004-03-01 00:00:002020-06-23 09:42:15Importance of serine 200 for functional activities of the hemagglutinin-neuraminidase protein of Newcastle Disease Virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / J. Neurooncol. 2004 Mar-Apr;67(1-2):83-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / J. Neurooncol. 2004 Mar-Apr;67(1-2):83-932004-03-01 00:00:002019-02-15 09:00:18MTH-68/H oncolytic viral treatment in human high-grade gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Curr. Opin. Mol. Ther. 2003 Dec;5(6):618-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Curr. Opin. Mol. Ther. 2003 Dec;5(6):618-242003-12-01 00:00:002019-02-15 09:22:25Overview of phase I studies of intravenous administration of PV701, an oncolytic virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-06-01 / Poult. Sci. 2003 Jun;82(6):899-906
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-06-01 / Poult. Sci. 2003 Jun;82(6):899-9062003-06-01 00:00:002019-02-15 09:22:26Recombinant Newcastle disease virus as a vaccine vector
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-15 / J. Immunol. 2003 Feb;170(4):1814-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-15 / J. Immunol. 2003 Feb;170(4):1814-212003-02-15 00:00:002020-06-23 09:42:47TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-09-01 / Am J Otolaryngol 2002 Sep-Oct;23(5):293-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-09-01 / Am J Otolaryngol 2002 Sep-Oct;23(5):293-62002-09-01 00:00:002019-02-15 08:51:32Postirradiation malignant fibrous histiocytoma of the larynx: a case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-932002-07-01 00:00:002020-06-23 09:44:19Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / J. Clin. Oncol. 2002 May;20(9):2251-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / J. Clin. Oncol. 2002 May;20(9):2251-662002-05-01 00:00:002019-02-15 09:22:28Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-12-01 / Cancer Res. 2001 Dec;61(23):8361-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-12-01 / Cancer Res. 2001 Dec;61(23):8361-52001-12-01 00:00:002001-12-01 00:00:00Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-10-22 / Cancer Lett. 2001 Oct;172(1):27-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-10-22 / Cancer Lett. 2001 Oct;172(1):27-362001-10-22 00:00:002019-02-15 09:22:29Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration
